Of note, LDHD, the most downstream enzyme of the GLO pathway, was detected only in very few samples of our cohort in both tumor and healthy tissue, with no striking change in abundance (Fig. 2; Supplementary Data 2). This evidence concerns the gene LDHD and neoplasm.